Jim Sullivan, Ph.D., is a Venture Partner with OrbiMed. Previously, Dr. Sullivan was the Vice President of Discovery at Abbvie, responsible for AbbVie’s research efforts in a variety of therapeutic/disease areas including oncology, immunology, neurology, hepatitis C and cystic fibrosis. Jim has advanced more than 100 compounds into clinical development across a number of disease states and technology platforms. He has authored/co-authored more than 130 scientific publications and is an inventor on 11 patents. Jim is an adjunct faculty member at Northwestern University and serves on the board of a number of companies and foundations. He earned his bachelor's degree and Ph.D. in biochemistry from Trinity College in Dublin, Ireland, and conducted post-doctoral research in neurobiology at Northwestern University.
BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives and biotech investors in a fireside chat.
© Illinois Science and Technology Coalition
Illustration by Dieter Braun